Concepedia

Determining Population and Developmental Pharmacokinetics of Metronidazole Using Plasma and Dried Blood Spot Samples From Premature Infants

Michael Cohen‐Wolkowiez, Mario R. Sampson, Barry T. Bloom, Antonio Arrieta, James L. Wynn, Karen Martz, Barrie Harper, Gregory L. Kearns, Edmund V. Capparelli, David S. Siegel,

The Pediatric Infectious Disease Journal · 2013 · 51 citations · 15 references

DOIFull text

Open access

Abstract

Simulations suggested the majority of infants in the neonatal intensive care unit (>80%) would meet the surrogate efficacy target using postmenstrual age-based dosing.

References

15

Neurodevelopmental and Functional Outcomes of Extremely Low Birth Weight Infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993–1994

Betty R. Vohr, Linda L. Wright, Anna M. Dusick et al. · PEDIATRICS · 2000 · 1.1K citations

Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience

E. Nagy, Edit Urbán, Carl Erik Nord · Clinical Microbiology and Infection · 2010 · 278 citations · Full text

, , +6

Model Appropriateness and Population Pharmacokinetic Modeling

Ene Ette, Paul J. Williams, Yong Ho Kim et al. · The Journal of Clinical Pharmacology · 2003 · 166 citations

, , +11

I.V. acetaminophen pharmacokinetics in neonates after multiple doses

Greta M. Palmer, M. E. Atkins, Brian J. Anderson et al. · British Journal of Anaesthesia · 2008 · 160 citations · Full text

, , +3

Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents

Laura Koeth · Journal of Antimicrobial Chemotherapy · 2004 · 90 citations · Full text